Amendment to Employment Agreements between ARIAD Pharmaceuticals, Inc. and Executive Officers

Summary

ARIAD Pharmaceuticals, Inc. amended its employment agreements with several executive officers in April or May 2007 to extend their employment terms. The new end dates for each officer's agreement range from 2010 to 2011, depending on the individual. After these dates, the agreements will automatically renew for one-year terms (three years for the CEO) unless either the company or the officer provides notice to end the agreement. This amendment ensures continued employment for the executives under the updated terms.

EX-10.2 3 a5466934ex10-2.htm EXHIBIT 10.2 a5466934ex10-2.htm

Exhibit 10.2

AMENDMENTS TO EMPLOYMENT AGREEMENTS

ARIAD Pharmaceuticals, Inc. (the “Company”) entered into an amendment to the employment agreement between the Company and each of the following executive officers, in April or May 2007, to extend the term of employment thereunder as follows:

		Term of Agreement Extended
Name and Title		From	To
		(December 31 of each year)
Harvey J. Berger, M.D. Chairman and Chief Executive Officer	2009		2011
Laurie A. Allen, Esq. Senior Vice President, Legal and Business Development,Chief Legal Officer and Secretary	2008		2010
David L. Berstein, Esq. Senior Vice President, Chief Patent Counsel	2008		2010
Timothy P. Clackson, Ph.D. Senior Vice President, Chief Scientific Officer	2008		2010
Edward M. Fitzgerald Senior Vice President, Finance and Corporate Operations,Chief Financial Officer and Treasurer	2008		2010
John D. Iuliucci, Ph.D. Senior Vice President, Chief Development Officer	2008		2010
Richard W. Pascoe Senior Vice President, Chief Commercial Officer	2007		2010

The term of employment for each officer is thereafter subject to automatic renewal for successive one-year terms (three-year terms in the case of Dr. Berger) absent notice to the contrary by either party.